Session 22 - Neurodegeneration
Emerging interventions and diagnostics

Programme

• 15:45 – 16:15 25 Min. 5 Min.

  • Invited Talk
  • S22-ND-T1

  Reasons for optimism in Alzheimer disease therapeutics

  • Bradley Hyman (Boston, MA, US)
• 16:15 – 16:45 25 Min. 5 Min.

  • Invited Talk
  • S22-ND-T2

  MEG3 activates necroptosis in human neuron xenografts modelling Alzheimer’s disease

  • Bart De Strooper (Leuven, BE)
• 16:45 – 16:55 7 Min. 3 Min.

  • Abstract Talk
  • S22-ND-A152

  Extracellular vesicles in blood – potential biomarkers for Alzheimer's Disease and differential diagnosis based on synaptic function and brain-region related proteins

  • Chen Tian (Hangzhou, CN)
• 16:55 – 17:05 7 Min. 3 Min.

  • Abstract Talk
  • S22-ND-A153

  Treatment with necroptosis-inhibitors reduces accumulation of necroptosis-related proteins and neuronal loss in APP23xTAU58 mice

  • Dietmar R. Thal (Leuven, BE)
• 17:05 – 17:15 7 Min. 3 Min.

  • Abstract Talk
  • S22-ND-A154

  Detection of alpha-synuclein in biopsies and surgical resections of peripheral organs in patients with isolated REM sleep behavior disorder

  • Iban Aldecoa (Barcelona, ES)